Harnessing the immunomodulatory capacity of dendritic cells differentiated from human induced pluripotent stem cells and the therapeutic potential of dendritic cell-derived exosome... by Leishman, A

Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance. by Leishman, A, Silk, K, Fairchild, P

Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset by Sachamitr, P, Leishman, A, Davies, T, Fairchild, P

Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype. by Silk, K, Leishman, A, Nishimoto, K, Reddy, A, Fairchild, P

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141 XCR1 dendritic cells by Silk, K, Silk, J, Ichiryu, N, Davies, T, Nolan, K, Leishman, A, Carpenter, L, Watt, S, Cerundolo, V, Fairchild, P

Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells. by Silk, K, Silk, J, Ichiryu, N, Davies, T, Nolan, K, Leishman, A, Carpenter, L, Watt, S, Cerundolo, V, Fairchild, P